Instituto do Coracao
São Paulo, 05403000, Brazil
NCT Number: NCT01450358
The objective of this study is to evaluate the consumption of antimicrobial therapy in patients comparing a rapid molecular test (PCR in Real-Time Multiplex) with blood cultures to identify the etiological agents of sepsis.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Phase 4
São Paulo, 05403000, Brazil
Patients staying more than 48 hours in hospital with clinical suspicion of sepsis could be included in the study. Blood samples for cultures and multiplex PCR will be collected immediately prior to initiation of antibiotic therapy. Patients will be randomly selected into two groups. In Group I, the PCR results will be immediately reported to the medical researcher (6-12 hours), which will change the antimicrobial regimen (De-escalation). In Group II, the Multiplex PCR results will not be informed, being focused care as a result of blood culture (at least after 72 hours). The initial empirical antimicrobial therapy will be the same in both groups, according to the standardization of the institution.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The medical researcher will change the antibiotic regimen (De-escalation) immediately as a result of Multiplex PCR (6-12 h).
Time frame: After fourteen days of antimicrobial treatment
Instituto do Coracao
Other Gov
Evaluation of Antimicrobial Use and Time of Treatment of Nosocomial Sepsis Comparing Polymerase Chain Reaction (PCR) in Real Time Multiplex to the Conventional Blood Culture for Etiologic Agents Identification. Randomized Clinical Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01359891
Bacteremia, Bacterial Infections
Graz, Styria, Austria
View Trial DetailsNCT00027248
Bacteremia, Bacterial Infections
Lake Bluff, Illinois, United States
View Trial DetailsNCT05950984
Adult Children, Antibiotic Resistant Infection
London, United Kingdom
View Trial DetailsNCT05314816
Bacteremia, Bacterial Infections
Guatemala City, Guatemala
View Trial Details